Cargando…
Mitochondria-specific drug release and reactive oxygen species burst induced by polyprodrug nanoreactors can enhance chemotherapy
Cancer cells exhibit slightly elevated levels of reactive oxygen species (ROS) compared with normal cells, and approximately 90% of intracellular ROS is produced in mitochondria. In situ mitochondrial ROS amplification is a promising strategy to enhance cancer therapy. Here we report cancer cell and...
Autores principales: | Zhang, Wenjia, Hu, Xianglong, Shen, Qi, Xing, Da |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461692/ https://www.ncbi.nlm.nih.gov/pubmed/30979885 http://dx.doi.org/10.1038/s41467-019-09566-3 |
Ejemplares similares
-
Author Correction: Mitochondria-specific drug release and reactive oxygen species burst induced by polyprodrug nanoreactors can enhance chemotherapy
por: Zhang, Wenjia, et al.
Publicado: (2019) -
Author Correction: Mitochondria-specific drug release and reactive oxygen species burst induced by polyprodrug nanoreactors can enhance chemotherapy
por: Zhang, Wenjia, et al.
Publicado: (2019) -
A mitochondria-targeted nanoradiosensitizer activating reactive oxygen species burst for enhanced radiation therapy
por: Li, Na, et al.
Publicado: (2018) -
Fabrication of pH/Redox Dual-Responsive Mixed Polyprodrug Micelles for Improving Cancer Chemotherapy
por: Luo, Ji, et al.
Publicado: (2022) -
Synthesis Characterization of Platinum (IV) Complex Curcumin Backboned Polyprodrugs: In Vitro Drug Release Anticancer Activity
por: Zhang, Honglei, et al.
Publicado: (2020)